Waterford Family Fights for Treatment and Awareness of Ultra-Rare CACNA1E Genetic Disorder
核心洞察
Only about 150 people worldwide are known to live with the ultra-rare genetic disorder CACNA1E (搜索), including 1-year-old Lorelei Dunn of Waterford, Michigan.
Lorelei's condition causes a seizure disorder, severe hypotonia, and feeding difficulties requiring a feeding tube, with few treatment options available.
After her insurance coverage was threatened in May, renewed coverage restored her chance at a gene therapy (搜索) proposed by a University of Michigan Medicine (搜索) neurologist.
A Waterford, Michigan family is working to raise awareness of CACNA1E (搜索), an ultra-rare genetic disorder that experts say affects only about 150 people worldwide. Among them is 1-year-old Lorelei Dunn, whose family says a lack of awareness makes finding treatment difficult and who are determined to change that.
Lorelei was diagnosed when she was just a few months old. Her mother, Kayleigh Dunn, describes the daily reality of caring for a child with one of the rarest genetic mutations in the world. "Because of that, it causes her to have a seizure disorder," Dunn said. "She has severe hypotonia. She cannot hold her head up. She has no trunk support. Because of some complications we've had with eating, she does have a feeding tube."
Lorelei's care requires a meticulous daily medication routine. "She gets these three twice a day, this one once a day," Dunn said. "These two I have to crush up and mix with water – which is a lot harder than you would think it is."
A Rare Diagnosis with Few Options
CACNA1E (搜索) is an ultra-rare genetic disorder, with only about 150 people in the world known to have the condition. Lorelei is one of only 30 people with her specific mutation. When the diagnosis came, the family was told their options were scarce and nearly nonexistent.
The family then connected with a renowned neurologist at University of Michigan Medicine (搜索), who told them about a specific gene therapy (搜索) that could help. Hopeful and grateful, the family wanted to move the process forward.
Insurance Uncertainty Threatens Treatment
In May, that possibility was nearly pulled out from under them when their insurance coverage was threatened. "If we had lost our coverage and we were going to have to move, see a different neurologist," Dunn said. "There was no neurologist in the state of Michigan that we found that would be willing to take this on. This is a big … to do what we want to do, they have to agree to a case study. It means long hours, extra shifts."
After Local 4 reported the family's story, the coverage was eventually extended. With that came renewed hope and Lorelei's chance at treatment.
Awareness as a Path to Research and Care
The family emphasizes that awareness fuels research, and research can open the door to lifesaving care. "She's proven time and time again that she is not defined by her mutation, but it's my life and it's tough. It's tough, right," Dunn said.
The family's advocacy comes as they mark CACNA1E (搜索) Awareness Day, hoping to draw attention to the importance of research and treatment for this ultra-rare condition.